CPLM 1.0 - Compendium of Protein Lysine Modification
TagContent
CPLM ID CPLM-001085
UniProt Accession
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
 Solute carrier family 22 member 2 
Protein Synonyms/Alias
 Organic cation transporter 2 
Gene Name
 Slc22a2 
Gene Synonyms/Alias
 Oct2 
Created Date
 July 27, 2013 
Organism
 Mus musculus (Mouse) 
NCBI Taxa ID
 10090 
Lysine Modification
Position
Peptide
Type
References
295RWLISQNKNAKAMKIubiquitination[1]
548KRIYLQVKKAELS**ubiquitination[1]
Reference
 [1] Proteomic analyses reveal divergent ubiquitylation site patterns in murine tissues.
 Wagner SA, Beli P, Weinert BT, Schölz C, Kelstrup CD, Young C, Nielsen ML, Olsen JV, Brakebusch C, Choudhary C.
 Mol Cell Proteomics. 2012 Dec;11(12):1578-85. [PMID: 22790023
Functional Description
 Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamin, creatinine, amantadine, memantine, acriflavine, 4-[4-(dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4-phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as DX-619 and LVFX. This transporter is a major determinant of the anticancer activity of oxaliplatin and may contribute to antitumor specificity (By similarity). 
Sequence Annotation
 CARBOHYD 71 71 N-linked (GlcNAc...) (Potential).  
Keyword
 Alternative splicing; Complete proteome; Glycoprotein; Ion transport; Membrane; Reference proteome; Transmembrane; Transmembrane helix; Transport. 
Sequence Source
 UniProt (SWISSPROT/TrEMBL); GenBank; EMBL 
Protein Length
 553 AA 
Protein Sequence
MPTVDDILEH IGEFHLFQKQ TFFLLALLSG AFTPIYVGIV FLGFTPNHHC RSPGVAELSQ 60
RCGWSPAEEL NYTVPGLGSA GEVSFLSQCM RYEVDWNQST LDCVDPLSSL AANRSHLPLS 120
PCEHGWVYDT PGSSIVTEFN LVCAHSWMLD LFQSLVNVGF FIGAVGIGYL ADRFGRKFCL 180
LVTILINAIS GVLMAISPNY AWMLVFRFLQ GLVSKAGWLI GYILITEFVG LGYRRTVGIC 240
YQIAFTVGLL ILAGVAYALP NWRWLQFAVT LPNFCFLLYF WCIPESPRWL ISQNKNAKAM 300
KIIKHIAKKN GKSVPVSLQS LTADEDTGMK LNPSFLDLVR TPQIRKHTLI LMYNWFTSSV 360
LYQGLIMHMG LAGDNIYLDF FYSALVEFPA AFIIILTIDR IGRRYPWAVS NMVAGAACLA 420
SVFIPDDLQW LKITVACLGR MGITIAYEMV CLVNAELYPT YIRNLAVLVC SSMCDIGGIV 480
TPFLVYRLTD IWLEFPLVVF AVVGLVAGGL VLLLPETKGK ALPETIEDAE KMQRPRKKKE 540
KRIYLQVKKA ELS 553 
Gene Ontology
 GO:0016323; C:basolateral plasma membrane; IEA:Compara.
 GO:0005887; C:integral to plasma membrane; ISA:MGI.
 GO:0015220; F:choline transmembrane transporter activity; IEA:Compara.
 GO:0015101; F:organic cation transmembrane transporter activity; IDA:MGI.
 GO:0015651; F:quaternary ammonium group transmembrane transporter activity; IEA:Compara.
 GO:0008513; F:secondary active organic cation transmembrane transporter activity; IEA:Compara.
 GO:0005496; F:steroid binding; IEA:Compara.
 GO:0051608; P:histamine transport; IEA:Compara. 
Interpro
 IPR020846; MFS_dom.
 IPR016196; MFS_dom_general_subst_transpt.
 IPR004749; Orgcat_transp.
 IPR005828; Sub_transporter.
 IPR005829; Sugar_transporter_CS. 
Pfam
 PF00083; Sugar_tr 
SMART
  
PROSITE
 PS50850; MFS
 PS00216; SUGAR_TRANSPORT_1
 PS00217; SUGAR_TRANSPORT_2 
PRINTS